Three therapies, when used in combination, may slow advanced melanoma, according to a new study led by researchers at UCLA. The study, published online ahead of print in the journal Nature Medicine (June 6, 2019) showed that the combination of dabrafenib, trametinib, and pembrolizaumab can slow the growth of advanced melanoma cancer cells.
HealthMinute.TV 